Small beginnings. Maximum cells.
MaxCell® is StemCyte's premium processing method. It tempers less with the cord blood and preserves four times the volume of a standard unit.
A better way to preserve.
Most cord blood banks reduce a unit to a concentrate, stripping out cells in the process. MaxCell® is StemCyte's proprietary processing method — engineered to preserve a higher recovery of total nucleated cells, keeping more of the cord blood that was there at birth.
Why this matters.
More cells, better odds
Total nucleated cell (TNC) count is a key predictor of engraftment success. Research has shown that higher TNC doses are associated with faster engraftment and better survival outcomes in cord blood transplants. MaxCell® processing preserves more TNCs than standard red blood cell depletion methods.
More options, later
A larger preserved unit gives future physicians flexibility. Some emerging cord blood therapies benefit from having a higher cell count or volume than a concentrated 25mL unit can provide. Preserving closer to the full 100mL of the original sample keeps more treatment pathways available — including applications not yet available.
Frequently asked questions
Start with more.
Plans with MaxCell® processing preserve four times the volume of standard processing — for whatever treatment the future holds.
Build your plan